| PERIOD ENDING |
28-Sep-07 |
| Total Revenue |
3,619,000 |
| Cost of Revenue |
2,708,000 |
|
| Gross Profit |
911,000 |
|
| Operating Expenses |
| Research Development |
-
|
| Selling General and Administrative |
401,000 |
| Non Recurring |
67,000 |
| Others |
-
|
| |
| Total Operating Expenses |
-
|
|
|
| Operating Income or Loss |
443,000 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
26,000 |
| Earnings Before Interest And Taxes |
469,000 |
| Interest Expense |
56,000 |
| Income Before Tax |
413,000 |
| Income Tax Expense |
146,000 |
| Minority Interest |
(3,000) |
| |
| Net Income From Continuing Ops |
264,000 |
|
| Non-recurring Events |
| Discontinued Operations |
(8,000) |
| Extraordinary Items |
-
|
| Effect Of Accounting Changes |
-
|
| Other Items |
-
|
|
|
| Net Income |
256,000 |
| Preferred Stock And Other Adjustments |
-
|
|
| Net Income Applicable To Common Shares |
$256,000 |
|
Help
Income Statement
Reuters offers more in-depth